Trials / Conditions / Miyoshi Myopathy
Miyoshi Myopathy
5 registered clinical trials studyying Miyoshi Myopathy — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | Clinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy (LGMD R2) NCT04824040 | Artgen Biotech | — |
| Unknown | Clinical Outcome Study for Dysferlinopathy NCT01676077 | Newcastle-upon-Tyne Hospitals NHS Trust | — |
| Completed | Dysferlinopathy Protein in Peripheral Blood Monocytes. NCT06507215 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | — |
| Withdrawn | Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Diso NCT01459302 | University of Massachusetts, Worcester | — |
| Completed | Deflazacort in Dysferlinopathies NCT00527228 | Ludwig-Maximilians - University of Munich | Phase 2 / Phase 3 |